Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02204020
Title Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Pittsburgh
Indications

acute myeloid leukemia

Therapies

Azacitidine

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field